The Promise of Novel Technology for the Prevention of Intravascular Device–Related Bloodstream Infection. II. Long‐Term Devices
- 15 May 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (10) , 1362-1368
- https://doi.org/10.1086/340105
Abstract
Intravascular devices (IVDs) are widely used for vascular access but are associated with a substantial risk of IVD-related bloodstream infection (BSI). The development of novel technologies based on our understanding of pathogenesis promises a quantum reduction in IVD-related infections in an era of growing nursing shortage. Infections of long-term IVDs (most are in place for ⩾10 days), including cuffed and tunneled central venous catheters (CVCs), implanted subcutaneous central venous ports, and peripherally inserted central catheters (PICCs), are primarily due to microorganisms that gain access to the catheter hub and lumen. Novel securement devices and antibiotic lock solutions have been shown to reduce the risk of IVD-related BSI in prospective randomized trials. The challenge for the future will be to identify new preventative technologies and to begin to more-widely adapt those technologies that have already been shown to be efficacious and cost effective.Keywords
This publication has 54 references indexed in Scilit:
- The Promise of Novel Technology for the Prevention of Intravascular Device–Related Bloodstream Infection. I. Pathogenesis and Short‐Term DevicesClinical Infectious Diseases, 2002
- Prospective Randomized Trial of 10% Povidone‐Iodine versus 0.5% Tincture of Chlorhexidine as Cutaneous Antisepsis for Prevention of Central Venous Catheter InfectionClinical Infectious Diseases, 2000
- Chlorhexidine Compared with Povidone-Iodine as Skin Preparation before Blood CultureAnnals of Internal Medicine, 1999
- Prevention of Central Venous Catheter-Related Infections by Using Maximal Sterile Barrier Precautions During InsertionInfection Control & Hospital Epidemiology, 1994
- Infective complications associated with the use of the Quinton ‘Permcath’ for long-term central vascular access in haemodialysisJournal of Hospital Infection, 1991
- Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial cathetersThe Lancet, 1991
- Central Venous Access for Haemodialysis Using the Hickman CatheterNephrology Dialysis Transplantation, 1989
- Bacteraemia related to indwelling central venous catheters: Prevention, diagnosis and treatmentEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- In situ management of confirmed central venous catheter-related bacteremiaThe Pediatric Infectious Disease Journal, 1987
- A Prospective Study of the Mechanisms of Infection Associated with Hemodialysis CathetersThe Journal of Infectious Diseases, 1986